GB2386069A - Consumable container - Google Patents

Consumable container Download PDF

Info

Publication number
GB2386069A
GB2386069A GB0303685A GB0303685A GB2386069A GB 2386069 A GB2386069 A GB 2386069A GB 0303685 A GB0303685 A GB 0303685A GB 0303685 A GB0303685 A GB 0303685A GB 2386069 A GB2386069 A GB 2386069A
Authority
GB
United Kingdom
Prior art keywords
container
contents
absorbed
substance
shell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0303685A
Other versions
GB2386069B (en
GB0303685D0 (en
Inventor
Leonard Louis Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Etablissement de Machines Industrielles
Original Assignee
Etablissement de Machines Industrielles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Etablissement de Machines Industrielles filed Critical Etablissement de Machines Industrielles
Publication of GB0303685D0 publication Critical patent/GB0303685D0/en
Publication of GB2386069A publication Critical patent/GB2386069A/en
Application granted granted Critical
Publication of GB2386069B publication Critical patent/GB2386069B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

A container 100 for consumption by a human or animal subject. The container comprises a shell 110 of sufficient strength to withstand storage/handling, which defines a closed cavity and which contains contents to be absorbed into the bloodstream of the subject and a substance that effervesces on contact with water. The nature of the shell is such that upon placing the container in the subject's mouth the shell ruptures in saliva to release the contents to be absorbed and the effervescent substance. A mixture is formed in the subject's mouth comprising the contents to be absorbed, the effervescent substance and saliva, which mixture is liable to effervesce.

Description

<Desc/Clms Page number 1>
TITLE: CONSUMABLE CONTAINER DESCRIPTION TECHNICAL FIELD The present invention relates to a container for consumption by a human or animal subject.
BACKGROUND ART Absorption into the bloodstream through the capillaries of the mouth confers certain advantages over absorption through the lining of the gut. For example, absorption through the capillaries of the mouth can be more rapid and more efficient. Furthermore, absorption in the mouth can enable safe transmission to the bloodstream
<Desc/Clms Page number 2>
of medicaments that are liable to be damaged, or perhaps even destroyed by gastric juices.
Absorption through the gut involves an absorbed substance passing through the various organs of the digestive system before the substance reaches the bloodstream. Much of the potency of an active ingredient in the substance can be lost during this process.
Absorption through the mouth, on the other hand, provides a more direct route to the bloodstream and this can help preserve the potency of an active ingredient.
The absorption of a medicament or the like through the gut often necessitates the conversion of the medicament during manufacture into the form of a salt.
The salt may be compressed into a pill or may be left in its powdered form and encapsulated either by itself or mixed with one or more vectors, which provide for stability, to create a pill or a capsule that performs in a least harmful manner whilst providing for delivery of the medicament to the bloodstream and to the desired parts of the body. The pill or capsule is swallowed by the consumer and the medicament converted back to its original form by the digestive system. A significant disadvantage of this approach is the reduction in the potency of the medicament that normally arises from the process of converting the medicament to a salt and converting the salt back to the medicament. A consequence of the reduction in potency can be an increase in the strength or quantity of the medicament. The increase in strength or
<Desc/Clms Page number 3>
quantity can cause damage, or perhaps even increase the damage caused to the digestive system and other body systems of the consumer.
Absorption of medicaments through the capillaries of the mouth has long been used as a means of treating ailments that require rapid relief. For example, angina has been treated for more than a century by the placing under the tongue of a capsule containing nitro-glycerine.
The nitro-glycerine containing capsule is cracked open with the teeth to release its contents. A single component gelatine capsule has often been used.
More complex capsule structures have been proposed.
Often, such capsule structures are designed to be swallowed by the consumer. One such gelatine capsule is described in GB 2283899. The capsule of GB 2283899 has a coating that is used to control and delay the release of an unpalatable medicament, preferably in the gut.
The above described single component nitro-glycerine containing capsule and more complex capsules-exemplified by that of GB 2283899-require time and effort on the part of the consumer to release their contents in the mouth. Clearly, a consumer may be loath to expend time and effort on sucking or chewing such a capsule, and may prefer to swallow it before its contents are released.
The inventors have realised that there is a need for a consumable container that is more inclined to release its contents in the mouth of a consumer.
The inventors have further determined that it would
<Desc/Clms Page number 4>
be advantageous to provide a mechanism such that absorption of the contents by the consumer's mouth lining is facilitated.
DISCLOSURE OF INVENTION According to a first aspect of the invention there is provided a container for consumption by a human or animal subject comprising a shell of sufficient strength to withstand storage/handling and defining a closed cavity, which contains contents to be absorbed into the bloodstream of the subject and a substance that effervesces on contact with water, wherein the nature of the shell is such that upon placing the container in the subject's mouth the shell ruptures in saliva to release the contents to be absorbed and the effervescent substance, thereby forming in the subject's mouth a mixture comprising the contents to be absorbed, the effervescent substance and saliva, which mixture is liable to effervesce.
The effervescence can facilitate absorption of the contents through the mouth lining by, for example, increasing the surface area of the contents brought into contact with the capillaries in the mouth.
More specifically, the shell may be an outer shell and the container may further comprise a closed substantially liquid impermeable inner container inside the closed cavity, which inner container is mechanically
<Desc/Clms Page number 5>
weak and protected by the outer shell and contains contents to be absorbed into the bloodstream, said contents being of a liquid nature.
During storage/handling the substantially liquid impermeable inner container may protect the outer shell from the liquid contents. The outer shell may protect the mechanically weak inner container during storage/handing.
The substance that effervesces on contact with water may be contained outside the closed inner container, e. g. between the inner container and the outer shell or perhaps even as part of the outer shell. This form of the invention may be useful where the effervescent substance is liable to effervesce in the presence of contents of a liquid nature.
Under certain circumstances, there may be insufficient water in the saliva of the subject's mouth to provide an effervescent mixture. Thus, water may be introduced into the subject's mouth to provide for effervescence.
The substance that effervesces on contact with water may comprise an alkali and an acid.
More specifically, the substance may comprise an alkaline bicarbonate and an organic acid, for example sodium bicarbonate and tartaric acid.
The shell may comprise a paper made from a cereal, such as rice or maize paper. Alternatively or in addition, the shell may comprise a mixture of gum arabica and wood fibres. In other words, the shell may comprise a tight
<Desc/Clms Page number 6>
fibrous substance.
The tight fibrous substance may consist of tightly packed fibres that lie for the most part in line with the surface of the outer shell. When constituted in this way, the shell can, when in contact with saliva, be more liable to be ruptured by a force applied in a direction that is generally perpendicular to the surface of the shell.
Thus, the shell can have sufficient rigidity and strength for storage and handling purposes, but can be less capable of withstanding a force that may be applied to the container when it is bought into contact with saliva upon being placed in the mouth. Such a force can include that exerted by the weight of the tongue or the pressure exerted by tissues in the mouth, e. g. the cheek, and can aid the break up caused by saliva.
Many substances degrade on exposure to air. Thus, according to certain embodiments the container may provide a substantially airtight seal for its contents. More specifically, the container may be substantially impermeable to an oxidising gas. The airtight seal or impermeable barrier might be provided by the inner container.
The container may be substantially opaque. Thus, the contents of the container can be shielded from the harmful effects of sunlight.
The inner container may comprise an ester of monohydric alcohols of the higher homologues, such as beeswax. A container according to such embodiments can
<Desc/Clms Page number 7>
have the desirable properties discussed above of providing a substantially airtight seal and/or of preventing liquid or moisture-containing contents from affecting the integrity of the outer shell. In addition, esters of monohydric alcohols of the higher homologues, such as beeswax, tend to undergo plastic deformation upon being placed in the mouth, thereby providing for the release of the contents to be absorbed. Plastic deformation can be caused by a rise in temperature (e. g. to body temperature), salivation, movement of the tongue and like masticatory actions. According to certain embodiments plastic deformation might, for example, be brought about within 0.5 to 60 seconds after the container is placed in the subject's mouth.
The container may further comprise a substantially indigestible component. The presence of the indigestible component in the consumable container can discourage a subject from swallowing the container and its contents.
More specifically, the inner container may comprise one or more of a plastics material, paraffin wax and bakelite.
In embodiments according to the last-preceding paragraph, the inner container may be provided with a coating of a wax, such as beeswax. Such a coating of wax can provide an airtight and moisture proof seal around the inner container.
Alternatively or in addition, the substantially indigestible component may be of a fibrous material
<Desc/Clms Page number 8>
contained, such as a ball of cotton wool. The fibrous material might, for example, be used to absorb the contents to be absorbed.
The inner container may have one of several forms.
According to one such form, the outer surface area of the inner container may be coextensive with the inner surface area of the outer shell, whereby the inner container lines the outer shell. More specifically, the inner container may be a membrane formed on the inside of the outer shell.
According to another form of the inner container, the outer surface area of the inner container may be substantially less than the inner surface area of the outer shell. Alternatively or in addition, the inner container may be a pouch provided loosely inside the outer shell.
The inner container may comprise a plurality of chambers. Alternatively or in addition, a plurality of inner containers may be contained within the outer shell and each inner container may have a chamber. A different substance may be contained within each of the plurality of chambers. More specifically, upon consumption of a container constituted according to such embodiments, the disposition of the chambers within the outer shell may be such that the contents of at least two chambers are released substantially simultaneously. Alternatively or in addition, the disposition of the chambers within the outer shell may be such that the contents of the plurality of chambers are released in a predetermined sequence. The
<Desc/Clms Page number 9>
period of time for release of contents from a chamber after being placed in the mouth may be controlled by providing an inner container with a predetermined solubility.
The contents to be absorbed may be in the form of one or more of a liquid, paste and a solid, such as a pill or powder. Such contents may be one or more of a medicament, a food supplement, a cosmetic, and a confectionery product. The contents might be mixed with a vector to ensure its stability.
According to a most favoured embodiment, the contents to be absorbed may comprise royal jelly. Alternatively or in addition, the contents to be absorbed may comprise honey.
BRIEF DESCRIPTION OF DRAWINGS A specific embodiment of the invention will now be described in detail, by way of example, and with reference to the accompanying drawings in which: Figure 1 shows a container being an embodiment of the present invention ; and Figure 2 is a flow chart representation of a method of manufacture of the container of Figure 1.
BEST MODE FOR CARRYING OUT THE INVENTION As shown in Figure 1, a container 100 according to the invention comprises an outer shell 110, which defines a closed cavity, and a closed inner container 120, which is
<Desc/Clms Page number 10>
provided as a membrane on the inner surface of the outer shell. The inner container has three chambers, which are formed by providing two separators 130 inside the inner container. A substance (constituting contents to be absorbed into the bloodstream), e. g. honey containing royal jelly, is provided in one of the chambers and a different substance (constituting contents to be absorbed into the bloodstream), such as Ginseng, Pollen or Ginko Biloba, is provided in each of the other two chambers. A mixture of sodium bicarbonate and tartaric acid (constituting a substance that effervesces in contact with water) is included with the substances contained in each chamber. A loose fibre ball 140 (constituting an indigestible component) is provided in the central chamber. Of course, a fibre ball can be provided in any one or more of the chambers.
The outer shell 110 is made of a tight fibrous substance such as rice or maize paper which ruptures and breaks up on being placed in the mouth of a consumer.
Pressure applied by the mouth of the consumer, e. g. by the tongue or cheek, can cause the outer shell to rupture. Saliva contributes to the break up of the container by causing the outer shell to disintegrate.
The inner container 120 is made of beeswax and provides an airtight seal for the contents of the container and prevents liquid or moisture containing contents from affecting the integrity of the outer shell. On being placed in the mouth, the temperature of the
<Desc/Clms Page number 11>
consumable container is raised to body temperature, which causes the inner container to soften and break up, thereby releasing the contents to be absorbed.
The loose fibre ball 140 is made of an indigestible material such as cotton wool. After the outer shell and inner container have broken up in the mouth of a consumer, the loose fibre ball 140 discourages the consumer from swallowing the residue. The loose fibre ball might, for example, be positioned under the tongue to bring the contents close to the large blood vessels located there.
Upon the breaking up of the outer shell and inner container, saliva comes into contact with the substances contained in the capsule chambers. The mixture of sodium bicarbonate and tartaric acid provided along with the substances in each chamber reacts with the water present in the saliva, thereby causing effervescence, i. e. the release of gas bubbles from the mixture. Water can be taken by the consumer along with the container to promote effervescence.
The consumable container 100 is saucer shaped, being circular when viewed from above and elongate when viewed from the side. The diameter of the consumable container is typically in the range of 10mm to 100mm and the height typically in the range of 3mm to 20mm.
A method of manufacture 200 of the consumable container 100 of Figure 1 will now be described with reference to Figure 2.
<Desc/Clms Page number 12>
A fibrous substance, made from the like of rice or maize, is formed into a paste and passed through rollers to form a thin sheet about 0.5mm to 1mm thick. The sheet is cut to provide two sheets of the same size.
One of the sheets is laid on an open mould, which has a given number of cavities, with each cavity being used to form an individual consumable container. The mould cavities are shaped to provide the separators 130 shown in Figure 1. A vacuum is applied to the underside of the sheet to cause the sheet to line the cavities. The mould is heated to dry the sheet and then allowed to cool rapidly 210.
The second un-moulded sheet is heated and allowed to cool rapidly to form the upper sheet 220.
One or more layers of a liquid impermeable substance, such as beeswax, a micro-thin plastics material, gelatine or a gelatine like substance are sprayed onto the upper surface of the moulded sheet and onto one of the surfaces of the upper sheet until the required thickness of impermeable substance has been deposited. The liquid impermeable substance is then allowed to dry 230.
Where the mould cavities are not shaped to form separators, separators 130 can be formed separately and positioned on the upper surface of the moulded sheet. The separators can be formed of the same fibrous substance as the moulded sheet.
The cavities in the moulded sheet are filled with the desired substance, e. g. honey containing royal jelly along
<Desc/Clms Page number 13>
with a mixture of sodium bicarbonate and tartaric acid, and a loose fibre ball placed in the central cavity 240.
The effervescent substance can be provided as a granular powder by the following method. The sodium bicarbonate and tartaric acid are pulverised separately, mixed, passed through sieves and moistened with a little alcohol to cause the pulverised particles to adhere to each other to form granules. The granules are then passed through a sieve having suitably sized meshes. After drying, the granules are graded by passing them through sieves of different sizes.
The upper sheet is placed over the moulded sheet, with the liquid impermeable substance towards the cavities, to enclose the contents of the cavities between upper and moulded sheets. The upper and moulded sheets are pressed together and a seal formed around each cavity with an appropriate tool, such as an ultrasonic welder or heat gun 250.
The sealed upper and moulded sheets are cut around each cavity to form individual consumable containers 260.
It is to be appreciated that the container and other features described with reference to the embodiment discussed above can be combined in other embodiments of the present invention.

Claims (23)

  1. CLAIMS: 1. A container for consumption by a human or animal subject comprising: a shell of sufficient strength to withstand storage/handling and defining a closed cavity, which contains contents to be absorbed into the bloodstream of the subject and a substance that effervesces on contact with water, wherein the nature of the shell is such that upon placing the container in the subject's mouth the shell ruptures in saliva to release the contents to be absorbed and the effervescent substance, thereby forming in the subject's mouth a mixture comprising the contents to be absorbed, the effervescent substance and saliva, which mixture is liable to effervesce.
  2. 2. A container as claimed in claim 1, in which the shell is an outer shell and the container further comprises a closed substantially liquid impermeable inner container inside the closed cavity, which inner container is mechanically weak and protected by the outer shell and contains contents to be absorbed into the bloodstream, said contents being of a liquid nature.
  3. 3. A container as claimed in claim 2, in which the substance that effervesces on contact with water is contained outside the closed inner container, e. g. between
    <Desc/Clms Page number 15>
    the inner container and the outer shell.
  4. 4. A container as claimed in any one of claims 1 to 3, in which the substance that effervesces on contact with water comprises an alkali and an acid.
  5. 5. A container as claimed in claim 4, in which the substance comprises an alkaline bicarbonate and an organic acid.
  6. 6. A container as claimed in any one of the preceding claims, in which the shell comprises a paper made from a cereal such as rice or maize.
  7. 7. A container as claimed in any preceding claim, in which the container provides a substantially airtight seal for its contents.
  8. 8. A container as claimed in any preceding claim, in which the container is substantially opaque.
  9. 9. A container as claimed in any one of claims 2 to 8, in which the inner container comprises an ester of monohydric alcohols of the higher homologues, such as beeswax.
  10. 10. A container as claimed in any preceding claim, in which the container further comprises a substantially
    <Desc/Clms Page number 16>
    indigestible component.
  11. 11. A container as claimed in any one of claims 2 to 10, in which the inner container comprises one or more of a plastics material, paraffin wax and bakelite.
  12. 12. A container as claimed in claim 10 or claim 11, in which the substantially indigestible component is a fibrous material, such as a ball of cotton wool.
  13. 13. A container as claimed in any one of claims 2 to 12, in which the outer surface area of the inner container is coextensive with the inner surface area of the outer shell, whereby the inner container lines the outer shell.
  14. 14. A container as claimed in claim 13, in which the inner container is a membrane formed on the inside of the outer shell.
  15. 15. A container as claimed in any of claims 2 to 14, in which the inner container comprises a plurality of chambers.
  16. 16. A container as claimed in claim 15, in which upon consumption of the container, the disposition of the chambers within the outer shell is such that the contents of at least two chambers are released substantially simultaneously.
    <Desc/Clms Page number 17>
  17. 17. A container as claimed in any one of the preceding claims, in which the contents to be absorbed are in the form of one or more of a liquid, paste and solid, such as a pill or powder.
  18. 18. A container as claimed in any preceding claim, in which the contents to be absorbed are one or more of a medicament, a food supplement, a cosmetic and a confectionery product.
  19. 19. A container as claimed in any preceding claim, in which the contents to be absorbed comprises royal jelly.
  20. 20. A container as claimed in any preceding claim, in which the contents to be absorbed comprises honey.
  21. 21. A container substantially as described herein and with reference to the accompanying drawings.
  22. 22. A drug or food supplement comprising a container as claimed in any one of the preceding claims.
  23. 23. A confection comprising a container as claimed in any one of the preceding claims.
GB0303685A 2002-02-20 2003-02-18 Consumable container Expired - Fee Related GB2386069B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0203984.0A GB0203984D0 (en) 2002-02-20 2002-02-20 Comsumable container

Publications (3)

Publication Number Publication Date
GB0303685D0 GB0303685D0 (en) 2003-03-19
GB2386069A true GB2386069A (en) 2003-09-10
GB2386069B GB2386069B (en) 2006-04-12

Family

ID=9931421

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0203984.0A Ceased GB0203984D0 (en) 2002-02-20 2002-02-20 Comsumable container
GB0303685A Expired - Fee Related GB2386069B (en) 2002-02-20 2003-02-18 Consumable container

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0203984.0A Ceased GB0203984D0 (en) 2002-02-20 2002-02-20 Comsumable container

Country Status (2)

Country Link
GB (2) GB0203984D0 (en)
TW (1) TW200303175A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627571A1 (en) * 2004-08-09 2006-02-22 Gebrüder Holzapfel GmbH &amp; Co. KG Device for the administration of dietary supplements
WO2009056297A1 (en) * 2007-10-31 2009-05-07 Pegasus Beratungs- Und Verwaltungs Ag Receptacle for effervescent powder
LU500113B1 (en) * 2021-04-30 2022-11-02 Marcel Hett Container for use in a liquid

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
US3823816A (en) * 1972-02-03 1974-07-16 Parke Davis & Co Water-soluble package
WO1997033596A1 (en) * 1996-03-14 1997-09-18 Peter Greither Process for preparing a storable preparation consisting of fresh plants, and fresh plant preparation
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
WO2000009090A1 (en) * 1998-08-12 2000-02-24 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
WO2001001992A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
WO2002007710A2 (en) * 2000-07-20 2002-01-31 Mw Encap Limited Delivery device
WO2002015887A1 (en) * 2000-08-17 2002-02-28 Machines Industrielles Etablissements Consumable container

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
US3823816A (en) * 1972-02-03 1974-07-16 Parke Davis & Co Water-soluble package
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
US5965110A (en) * 1990-11-02 1999-10-12 Arnold; Michael J. Plaque adsorbent oral composition and method
WO1997033596A1 (en) * 1996-03-14 1997-09-18 Peter Greither Process for preparing a storable preparation consisting of fresh plants, and fresh plant preparation
WO2000009090A1 (en) * 1998-08-12 2000-02-24 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
WO2001001992A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
WO2002007710A2 (en) * 2000-07-20 2002-01-31 Mw Encap Limited Delivery device
WO2002015887A1 (en) * 2000-08-17 2002-02-28 Machines Industrielles Etablissements Consumable container

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627571A1 (en) * 2004-08-09 2006-02-22 Gebrüder Holzapfel GmbH &amp; Co. KG Device for the administration of dietary supplements
WO2009056297A1 (en) * 2007-10-31 2009-05-07 Pegasus Beratungs- Und Verwaltungs Ag Receptacle for effervescent powder
LU500113B1 (en) * 2021-04-30 2022-11-02 Marcel Hett Container for use in a liquid

Also Published As

Publication number Publication date
TW200303175A (en) 2003-09-01
GB0203984D0 (en) 2002-04-03
GB2386069B (en) 2006-04-12
GB0303685D0 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
US4305502A (en) Pharmaceutical dosage form packges
US20190029923A1 (en) Method and apparatus for forming delivery devices for oral intake of an agent
KR102284971B1 (en) Capsule dispensing container
KR101542038B1 (en) Method and Composition for Making an Orally Disintegrating Dosage Form
CN100553621C (en) The pharmaceutical dosage form of multicomponent
RU2448026C2 (en) Package with pharmaceutical preparations
IE45770B1 (en) Pharmaceutical dosage forms
JP5009903B2 (en) Edible film packaging with oral products
GB2205496A (en) Therapeutic pack
WO2004043351A2 (en) Soluble oral patch with collagen and interlaced active ingredients
EP1838292B1 (en) Preparation for preventing or treating calcium deficiency conditions in mammals
EA014825B1 (en) Method for stabilising pharmaceutical administration forms that contain micro-organisms
US20060062833A1 (en) Wound dressing
US20040022972A1 (en) Consumable container
US5958450A (en) Method of drug delivery and coated oral dosage forms for use in the method
GB2386069A (en) Consumable container
CN100589793C (en) Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, the system and the preparation of the enveloping substance of the system
WO2010114822A1 (en) Menthol-melatonin dissolving film
AU2003287313A1 (en) Soluble oral patch with collagen and interlaced active ingredients
WO2011027795A1 (en) Preparation for oral administration
US20180200191A1 (en) Multi Component Pill and Method(s) of Use
CN213346933U (en) Tea-seed oil soft capsule convenient to tear
EP3975972B1 (en) Process for the conditioned packaging of hard gelatin capsules
Bogdan et al. Methodology of creating an encapsulated dosage form with bee products. Report ІІ
Bogdan et al. Methodology of creating an encapsulated dosage form with bee products. Report II

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20070218